DanielEBauerMDPhD
Pediatric Hematology & Oncology • Boston, MAPediatric Anemia and Red Blood Cell Hematology
Staff Physician, Boston Children's Hospital and Dana-Farber Cancer Institute / Associate Professor of Pediatrics, Harvard Medical School
Dr. Bauer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-3000Fax+1 617-632-4773
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2008 - 2012- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2006 - 2008
Perelman School of Medicine at the University of PennsylvaniaClass of 2006
Certifications & Licensure
MA State Medical License 2008 - 2025- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells.Jing Zeng, My Anh Nguyen, Pengpeng Liu, Lucas Ferreira da Silva, Sébastien Levesque
Cell Stem Cell. 2024-12-11 - BCL11A +58/+55 enhancer-editing facilitates HSPC engraftment and HbF induction in rhesus macaques conditioned with a CD45 antibody-drug conjugate.Selami Demirci, Jing Zeng, Rahul Palchaudhuri, Chuanfeng Wu, Diana M Abraham
Cell Stem Cell. 2024-12-05 - CRISPR-CLEAR: Nucleotide-Resolution Mapping of Regulatory Elements via Allelic Readout of Tiled Base Editing.Basheer Becerra, Sandra Wittibschlager, Zain M Patel, Ana P Kutschat, Justin Delano
Biorxiv. 2024-09-09
Journal Articles
- CRISPRO: Identification of Functional Protein Coding Sequences Based on Genome Editing Dense MutagenesisDaniel Bauer, MD, BioMed Central
Abstracts/Posters
- Durable and Robust Fetal Globin Induction without Anemia in Rhesus Monkeys Following Autologous Hematopoietic Stem Cell Transplant with BCL11A Erythroid Enhancer EditingDaniel E. Bauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- CRISPR-Cas9 Screen Identifies XPO7 As a Potential Therapeutic Target for TP53-Mutated AMLDaniel E. Bauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Therapeutic Base Editing of Human Hematopoietic Stem CellsDaniel E. Bauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Transcriptional Signaling Centers Govern Human Erythropoiesis and Harbor Genetic Variations of Red Blood Cell Traits2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Opportunities for Scientists in Hematology: Nothing Basic About Discovery60th American Society of Hematology Annual Meeting - 11/30/2018
Press Mentions
Boston Woman Adopts 3 Girls That Have Same Incurable Blood Disease She Has: ‘It’s a Miracle We Found Each Other’June 12th, 2017- Patients with Sickle Cell Disease Urge FDA to Greenlight Landmark Gene-Editing TreatmentNovember 2nd, 2023
- Potential Cure for Sickle Cell Clears Hurdle for ApprovalNovember 2nd, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
